Search

Your search keyword '"Taille, Camille"' showing total 141 results

Search Constraints

Start Over You searched for: Author "Taille, Camille" Remove constraint Author: "Taille, Camille"
141 results on '"Taille, Camille"'

Search Results

2. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

3. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

5. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

7. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

9. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

10. French recommendations for the diagnosis and management of lymphangioleiomyomatosis

11. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

12. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

17. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

22. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study

24. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

25. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

27. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

28. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

29. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

30. Severity and phenotypes of dyspnea in asthma: impact of comorbidities

34. Benralizumab for eosinophilic granulomatosis with polyangiitis

38. Is telomere length a predictor of long-term survival in patients with COVID-19 pneumonia?

40. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

42. Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia

50. Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia

Catalog

Books, media, physical & digital resources